153 related articles for article (PubMed ID: 20106347)
1. Current therapeutic recommendations in multiple sclerosis.
Berger T
J Neurol Sci; 2009 Dec; 287 Suppl 1():S37-45. PubMed ID: 20106347
[TBL] [Abstract][Full Text] [Related]
2. [Long-term effects of glatiramer acetate in multiple sclerosis].
Brochet B
Rev Neurol (Paris); 2008 Nov; 164(11):917-26. PubMed ID: 18790510
[TBL] [Abstract][Full Text] [Related]
3. New options for early treatment of multiple sclerosis.
Tintoré M
J Neurol Sci; 2009 Feb; 277 Suppl 1():S9-S11. PubMed ID: 19200870
[TBL] [Abstract][Full Text] [Related]
4. Implications of neutralising antibodies on therapeutic efficacy.
Bertolotto A
J Neurol Sci; 2009 Feb; 277 Suppl 1():S29-32. PubMed ID: 19200862
[TBL] [Abstract][Full Text] [Related]
5. Concepts of induction and escalation therapy in multiple sclerosis.
Rieckmann P
J Neurol Sci; 2009 Feb; 277 Suppl 1():S42-5. PubMed ID: 19200866
[TBL] [Abstract][Full Text] [Related]
6. Early treatment: PreCISe-ly what the patient needs.
Montalban X
J Neurol Sci; 2009 Dec; 287 Suppl 1():S2-6. PubMed ID: 20106344
[TBL] [Abstract][Full Text] [Related]
7. [Update on current care guidelines: diagnostics, treatment and rehabilitation of multiple sclerosis].
Elovaara I; Atula S; Erälinna JP; Färkkilä M; Pirttilä T; Remes A; Ruutiainen J; Varis T; ;
Duodecim; 2010; 126(2):199-200. PubMed ID: 20405605
[TBL] [Abstract][Full Text] [Related]
8. [Immunomodulatory therapy in multiple sclerosis].
Csépány T; Bereczki D
Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
[TBL] [Abstract][Full Text] [Related]
9. Disease-modifying drugs for the early treatment of multiple sclerosis.
Flachenecker P
Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
[TBL] [Abstract][Full Text] [Related]
10. Lessons from randomised direct comparative trials.
Achiron A; Fredrikson S
J Neurol Sci; 2009 Feb; 277 Suppl 1():S19-24. PubMed ID: 19200860
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological treatment of multiple sclerosis].
Myhr KM
Tidsskr Nor Laegeforen; 2010 Mar; 130(5):490-2. PubMed ID: 20224616
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis: interferon beta for some serious forms.
Prescrire Int; 2007 Dec; 16(92):252-7. PubMed ID: 18092425
[TBL] [Abstract][Full Text] [Related]
13. Natalizumab: new drug. Multiple sclerosis: risky market approval.
Prescrire Int; 2008 Feb; 17(93):7-10. PubMed ID: 18354844
[TBL] [Abstract][Full Text] [Related]
14. Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode.
Goodin DS; Bates D
Mult Scler; 2009 Oct; 15(10):1175-82. PubMed ID: 19737851
[TBL] [Abstract][Full Text] [Related]
15. [Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary].
Mezei Z; Bereczki D; Csiba L; Csépány T
Ideggyogy Sz; 2006 Nov; 59(11-12):442-7. PubMed ID: 17203882
[TBL] [Abstract][Full Text] [Related]
16. Glatiramer acetate in treatment-naïve and prior interferon-beta-1b-treated multiple sclerosis patients.
Zwibel HL;
Acta Neurol Scand; 2006 Jun; 113(6):378-86. PubMed ID: 16674604
[TBL] [Abstract][Full Text] [Related]
17. The gap between effect of drugs and effectiveness of treatments.
Sorensen PS
J Neurol Sci; 2007 Aug; 259(1-2):128-32. PubMed ID: 17362994
[TBL] [Abstract][Full Text] [Related]
18. Current disease-modifying therapies in multiple sclerosis.
Kieseier BC; Hartung HP
Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
[TBL] [Abstract][Full Text] [Related]
19. The therapy of multiple sclerosis with immune-modulating or immunosuppressive drug. A critical evaluation based upon evidence based parameters and published systematic reviews.
Clerico M; Rivoiro C; Contessa G; Viglietti D; Durelli L
Clin Neurol Neurosurg; 2008 Nov; 110(9):878-85. PubMed ID: 18164542
[TBL] [Abstract][Full Text] [Related]
20. Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study.
Gauthier SA; Glanz BI; Mandel M; Tsagkaropoulos A; Neema M; Stankiewicz J; Arora A; Duan Y; Liptak Z; Egorova S; Buckle GJ; Bakshi R; Guttmann CR; Khoury SJ; Weiner HL
J Neurol Sci; 2009 Sep; 284(1-2):116-9. PubMed ID: 19428028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
